Cargando…

Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells

An in vitro drug-induced cardiotoxicity assay is a critical step in drug discovery for clinical use. The use of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) is promising for this purpose. However, single hiPSC-CMs are limited in their ability to mimic native cardiac tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeda, Maki, Miyagawa, Shigeru, Fukushima, Satsuki, Saito, Atsuhiro, Ito, Emiko, Harada, Akima, Matsuura, Ryohei, Iseoka, Hiroko, Sougawa, Nagako, Mochizuki-Oda, Noriko, Matsusaki, Michiya, Akashi, Mitsuru, Sawa, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757089/ https://www.ncbi.nlm.nih.gov/pubmed/28967302 http://dx.doi.org/10.1089/ten.tec.2017.0247

Ejemplares similares

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Development of a drug screening system using three-dimensional cardiac tissues containing multiple cell types
por: Takeda, Maki, et al.
Publicado: (2021)

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
por: Sougawa, Nagako, et al.
Publicado: (2018)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

Combined administration of laminin-221 and prostacyclin agonist enhances endogenous cardiac repair in an acute infarct rat heart
por: Sougawa, Nagako, et al.
Publicado: (2021)

Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model
por: Iseoka, Hiroko, et al.
Publicado: (2020)

Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice
por: Imanishi, Yukiko, et al.
Publicado: (2013)

Eliminating residual iPS cells for safety in clinical application
por: Masuda, Shigeo, et al.
Publicado: (2015)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
por: Mori, Daisuke, et al.
Publicado: (2019)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
por: Domae, Keitaro, et al.
Publicado: (2021)

Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model
por: Ito, Emiko, et al.
Publicado: (2023)

Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
por: Yajima, Shin, et al.
Publicado: (2019)

Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats
por: Kainuma, Satoshi, et al.
Publicado: (2017)

Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
por: Miyagawa, Shigeru, et al.
Publicado: (2016)

Intravital imaging with two-photon microscopy reveals cellular dynamics in the ischeamia-reperfused rat heart
por: Matsuura, Ryohei, et al.
Publicado: (2018)

Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts
por: Tadano, Kiyoshi, et al.
Publicado: (2021)

Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarction
por: Nakazato, Taro, et al.
Publicado: (2022)

Irradiation strongly reduces tumorigenesis of human induced pluripotent stem cells
por: Inui, Shoki, et al.
Publicado: (2017)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

3D puzzle-inspired construction of large and complex organ structures for tissue engineering
por: Xie, Zheng-Tian, et al.
Publicado: (2023)

N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Kawamura, Takuji, et al.
Publicado: (2014)

Laminin‐221 Enhances Therapeutic Effects of Human‐Induced Pluripotent Stem Cell–Derived 3‐Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model
por: Samura, Takaaki, et al.
Publicado: (2020)

Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
por: Ohkawara, Hirotatsu, et al.
Publicado: (2018)

A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015)

Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts
por: Kashiyama, Noriyuki, et al.
Publicado: (2019)

Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype
por: Yokoyama, Junya, et al.
Publicado: (2021)

High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells
por: Goto, Takasumi, et al.
Publicado: (2020)

Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice
por: Kawamura, Ai, et al.
Publicado: (2016)

Fabrication of highly stretchable hydrogel based on crosslinking between alendronates functionalized poly-γ-glutamate and calcium cations
por: Nakamoto, Masahiko, et al.
Publicado: (2022)

Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease
por: Miyake, Keisuke, et al.
Publicado: (2022)

Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice
por: Kashiyama, Noriyuki, et al.
Publicado: (2016)

Three‐dimensional cultured tissue constructs that imitate human living tissue organization for analysis of tumor cell invasion
por: Iwai, Soichi, et al.
Publicado: (2018)

Construction of transplantable artificial vascular tissue based on adipose tissue-derived mesenchymal stromal cells by a cell coating and cryopreservation technique
por: Asano, Yoshiya, et al.
Publicado: (2021)

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
por: Yoshida, Shohei, et al.
Publicado: (2018)

Comparison of Arrhythmogenicity and Proinflammatory Activity Induced by Intramyocardial or Epicardial Myoblast Sheet Delivery in a Rat Model of Ischemic Heart Failure
por: Pätilä, Tommi, et al.
Publicado: (2015)

Rapid and sensitive mycoplasma detection system using image-based deep learning
por: Iseoka, Hiroko, et al.
Publicado: (2021)

Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
por: Masada, Kenta, et al.
Publicado: (2020)

Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_34vbbihokbhv90h4h2mrkkhk59